H. Jernberg-Wiklund
发表
K. Nilsson,
H. Jernberg-Wiklund,
2002
.
P. Georgii‐Hemming,
K. Nilsson,
H. Jernberg-Wiklund,
2002,
European journal of haematology.
O. Söderberg,
K. Nilsson,
H. Jernberg-Wiklund,
1997,
British journal of haematology.
M. Pettersson,
K. Nilsson,
H. Jernberg-Wiklund,
1991
.
B. Sander,
K. Stamatopoulos,
J. Rung,
2015
.
S. Karlsson,
M. Essand,
K. Nilsson,
2013,
Cancer Gene Therapy.
H. Döhner,
R. Rosenquist,
S. Stilgenbauer,
2006,
Leukemia.
O. Larsson,
M. Axelson,
L. Girnita,
2006,
Blood.
B. Sander,
K. Stamatopoulos,
A. Isaksson,
2012,
American journal of hematology.
A. Dimberg,
K. Carlson,
H. Jernberg-Wiklund,
2013
.
W. Matsui,
Q. Wang,
K. Vanderkerken,
2012,
Leukemia.
O. Larsson,
P. Agarwal,
F. Haglund,
2017,
Journal of cellular physiology.
O. Larsson,
D. Vasilcanu,
Yingbo Lin,
2011,
Biochemical and biophysical research communications.
O. Larsson,
M. Axelson,
P. Croucher,
2007,
International journal of cancer.
O. Larsson,
U. Hellman,
M. Axelson,
2006,
Blood.
O. Larsson,
U. Hellman,
M. Axelson,
2013
.
O. Larsson,
P. Atadja,
M. Axelson,
2012,
Clinical Cancer Research.
O. Larsson,
P. Atadja,
M. Axelson,
2012
.
O. Larsson,
P. Atadja,
M. Axelson,
2012
.
K. Nilsson,
Marina Tshuikina,
H. Jernberg-Wiklund,
2008,
Experimental hematology.
P. Kokhaei,
A. Österborg,
M. Kubbies,
2007,
Clinical Cancer Research.
P. Georgii‐Hemming,
K. Nilsson,
H. Jernberg-Wiklund,
1998,
Blood.
J. Fraczek,
V. Rogiers,
K. Vanderkerken,
2013
.
L. Feuk,
Jonatan Halvardson,
A. Zaghlool,
2016,
Human mutation.
H. Nahi,
K. Nilsson,
F. Öberg,
2016,
Oncotarget.
A. Lennartsson,
H. Jernberg-Wiklund,
Alba Atienza Párraga,
2021,
Epigenomes.
H. Jernberg-Wiklund,
Alba Atienza Párraga,
Mohammad Alzrigat,
2017,
Seminars in cancer biology.
K. Nilsson,
H. Jernberg-Wiklund,
2012,
Upsala journal of medical sciences.
M. Pettersson,
K. Nilsson,
H. Jernberg-Wiklund,
1992,
International journal of cancer.
J. Licht,
H. Jernberg-Wiklund,
Mohammad Alzrigat,
2018,
Epigenomes.
K. Nilsson,
A. Osterborg,
A. Dimberg,
2004,
Blood.
H. Nahi,
C. Heckman,
K. Nilsson,
2017,
Oncotarget.
L. Larsson,
Y. Tsujimoto,
M. Pettersson,
1992,
Blood.
IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms.
P. Atadja,
F. Schuit,
Lieven Thorrez,
2010,
Blood.
K. Nilsson,
H. Jernberg-Wiklund,
2007,
Advances in cancer research.
B. Sander,
K. Stamatopoulos,
J. Rung,
2015
.
P. Georgii‐Hemming,
K. Nilsson,
H. Jernberg-Wiklund,
1999,
Current topics in microbiology and immunology.
O. Larsson,
C. Larsson,
W. Lui,
2011,
PloS one.
H. Jernberg-Wiklund,
Y. Paulsson-Karlsson,
K. Ivarsson,
2006,
Biochemical and biophysical research communications.
J. Licht,
H. Jernberg-Wiklund,
Mohammad Alzrigat,
2018
.
Jessica M. Rusert,
O. Sangfelt,
R. Wechsler-Reya,
2022,
Cancer research.
B. Zhivotovsky,
P. Johnsson,
D. Grandér,
2012,
Cancer research.
S. Karlsson,
M. Essand,
K. Nilsson,
2013,
Cancer Gene Therapy.
P. Atadja,
K. Nilsson,
F. Öberg,
2010,
PloS one.
Stefan Enroth,
K. Nilsson,
F. Öberg,
2016,
Oncotarget.
H. Jernberg-Wiklund,
Mohammad Alzrigat,
2017,
RNA & disease.
J. Haglöf,
F. Öberg,
Jian Jin,
2021,
Cell Death & Disease.
M. Pettersson,
K. Nilsson,
H. Jernberg-Wiklund,
1992,
Leukemia.
O. Larsson,
P. Agarwal,
F. Haglund,
2017
.
The IGF-1 receptor inhibitor picropodophyllin potentiates the anti-myeloma activity of a BH3-mimetic
O. Larsson,
H. Johnsen,
M. Nyegaard,
2014,
Oncotarget.
L. Binderup,
K. Nilsson,
R. Larsson,
2004,
Anti-cancer drugs.
O. Larsson,
D. Vasilcanu,
Yingbo Lin,
2011,
Biochemical and biophysical research communications.
K. Stamatopoulos,
Xiao-Jie Yan,
N. Chiorazzi,
2015,
The Journal of experimental medicine.
K. Nilsson,
H. Jernberg-Wiklund,
2004
.